EUVIMEDEUVIMED entdecken
Crossref

Endobiliary radiofrequency ablation – a promising new tool to prolong stent patency in patients with malignant biliary obstruction

Y. Petkova, P. Karagyozov, I. Tishkov

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S354-S355

DOI: 10.1055/s-0044-1783568 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von Y. Petkova und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The main approach for the management of unresectable malignant biliary obstruction is ERCP with stenting followed by palliative chemotherapy. However, a major concern is the rate of recurrent biliary obstruction/RBO/. Endobilliary radiofrequency ablation (EB-RFA) is a new endoscopic technique that can be an adjunctive tool in prolonging the period of stent patency and patient survival.The primary endpoints were to evaluate the correlation between the period of stent patency,type of placed stents and subsequent chemotherapy in patients with malignant biliary obstruction/MBO/treated with ЕB-RFA. Secondary endpoints were the overall efficacy and safety of the procedure in terms of survival and adverse events/AE/.

Methods

We performed a retrospective analysis of a prospective database including all consecutive patients who underwent EB-RFA for the period July 2021 – November 2023.26 procedures in 24 patients who were unresectable or poor surgical candidates were performed. Endobiliary RFA/EB-RFA /catheter (ELRA, STARmed, Taewoong Medical) and RF generator system (VIVA combo, STARmed) were used in 24 of the procedures. After passing a guidewire the catheter was positioned at the targeted lesion, followed by 120 s of ablation (target temperature 80°C, 7–10 W, temperature control mode.

Results

The patients were divided in two groups of patients depending on the type of stent placed – 7 patients with plastic stents after RFA,and 17 patients with metal. The mean period of stent patency defined as the time between the date of the procedure and the last follow-up of the patient without signs of stent occlusion was 261.50 (142.50+/-312.75) days. For the group with plastic stents, the period was 196.57±101.83 days, and 260.29±132.05 days for the group with metal stents – the difference was not statistically significant. In 15 patients/62,5%/ there was chemotherapy with Paclitaxel/Gemcitabine after the procedure – in 2 patients with plastic stents/8,3%/ and 13 patients /54,2%/with metal. We found an association between the period of stent patency and symptom-free survival and placement of metal stents followed by chemotherapy – Pearson χ2 test=4.854, p=0.028. The longest period of stent patency is observed in patients who receive metal stents and chemotherapy after EB-RFA. The rate of the AE was 18.75%/n=3/ – one patient with self-limited bleeding; one patient with postprocedural cholangitis and one patient with postprocedural biloma. There were no deaths or ICU admissions. We experienced four episodes of RBO – two managed with a second session of RFA and two only with stent exchange.

Conclusions

ID-RFA combined with the placement of metal stents followed by chemotherapy is a promising tool to improve outcomes in patients with MBO with high efficacy and a good safety profile. Therefore ID-RFA can be proposed as adjunctive treatment in patients with MBO although more randomized studies are needed. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Petkova, Y., Karagyozov, P., & Tishkov, I. (2024). Endobiliary radiofrequency ablation – a promising new tool to prolong stent patency in patients with malignant biliary obstruction. Endoscopy, 56(S 02 S 02), S354-S355. https://doi.org/10.1055/s-0044-1783568

Vancouver

Petkova Y, Karagyozov P, Tishkov I. Endobiliary radiofrequency ablation – a promising new tool to prolong stent patency in patients with malignant biliary obstruction. Endoscopy. 2024;56(S 02 S 02):S354-S355. doi:10.1055/s-0044-1783568

BibTeX
@article{Petkova2024,
  author = {Petkova, Y. and Karagyozov, P. and Tishkov, I.},
  title = {Endobiliary radiofrequency ablation – a promising new tool to prolong stent patency in patients with malignant biliary obstruction},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S354--S355},
  doi = {10.1055/s-0044-1783568}
}
Kostenlos starten →